Jazz Pharmaceuticals Director Files Form 144 Notice of Proposed Sale
Jazz Pharmaceuticals plc
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 144 Notice: Jazz Pharmaceuticals plc ($JAZZ) Insider: RIEDEL NORBERT G (Director) Proposed Transaction: Sale of 3,507 Common Shares (~$857,602.00) Approx. Sale Date: 2026-08-31 Broker: E*TRADE Financial Corporation Source of Shares: Restricted Stock Vesting (Acquired 08/28/2026)
Comprehensive Analysis
Insider Filing Analysis: Form 144 (Proposed Sale)
Summary
- Issuer: Jazz Pharmaceuticals plc (
JAZZ/ CIK:0001232524) - Insider: Norbert G. Riedel (Director / CIK:
0001161662) - Filing Date: August 31, 2026
- Proposed Sale Date: August 31, 2026
Transaction Details
- Securities to be Sold: 3,507 Common Shares
- Estimated Aggregate Market Value: $857,602.00 (~$244.54 per share)
- Broker: E*TRADE Financial Corporation
- Origin of Shares: Acquired via Restricted Stock Vesting on August 28, 2026, as compensation from the issuer.
- Past 3 Months Activity: No prior sales reported in the preceding 3 months.
Significance
- Trading Significance: Low
- Context: The proposed sale represents a modest volume (3,507 shares) relative to Jazz Pharmaceuticals' 64,914,577 shares outstanding. It originates directly from newly vested restricted stock units, reflecting standard liquidity management following equity compensation vesting.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.